Abstract
Obesity mediates most of its direct medical sequelae through the development of insulin resistance (IR). The cellular effects of insulin occur through two main postreceptor pathways that are the phosphatidylinositol 3-kinase (PI3-K) and the mitogen-activated protein kinase (MAP-K) pathways. Obesity-related IR implicates the PI3-K pathway that confers the metabolic effects of insulin. Numerous and complex pathogenic pathways link obesity with the development of IR, including chronic inflammation, mitochondrial dysfunction (with the associated production of reactive oxygen species and endoplasmic reticulum stress), gut microbiota dysbiosis and adipose extracellular matrix remodelling. IR itself plays a key role in the development of metabolic dysfunction, including hypertension, dyslipidaemia and dysglycaemia. Furthermore, IR promotes weight gain related to secondary hyperinsulinaemia, with a resulting vicious cycle of worsening IR and its metabolic sequelae. Ultimately, IR underlies obesity-related conditions such as type 2 diabetes mellitus (T2D) and polycystic ovary syndrome (PCOS). IR also underlies many obesity-related malignancies, through the effects of compensatory hyperinsulinaemia on the relatively intact MAP-K insulin pathway, which controls cellular growth processes and mitoses. Furthermore, the emergent data over recent decades support an important role of obesity- and T2D-related central IR in the development of cognitive dysfunction, including effects on hippocampal synaptic plasticity. Importantly, IR is largely reversible through the optimisation of lifestyle factors that include regular engagement in physical activity with the avoidance of sedentariness, improved diet including increased fibre intake and sleep sufficiency. IR lies at the key crossroad between obesity and both metabolic and cognitive dysfunction. Given the importance of IR in the pathogenesis of many 21st century chronic diseases and its eminent reversibility, it is important that we all embrace and facilitate optimised lifestyles to improve the future health and wellbeing of the populace.
Highlights
In addition to malignancies such as endometrial carcinoma [1,3], insulin resistance (IR) underlies the cardio-metabolic dysfunction that associates with obesity
Having explored the complex pathways that mediate effects of obesity on the development of IR, we provide an overview of the mechanisms by which IR contributes towards metabolic dysfunction
There are variable underlying pathogeneses for these numerous comorbidities. These range from mechanical effects of obesity from pressure on weightbearing joints, restrictions of breathing and restrictions of the upper airways in obstructive sleep apnoea to the effects of obesity-related societal views, prejudices and stigma on the development of depression and other mental health problems, including adverse impact on overall emotional wellbeing, self-esteem and general productivity [1]
Summary
In addition to malignancies such as endometrial carcinoma [1,3], IR underlies the cardio-metabolic dysfunction that associates with obesity. This includes type 2 diabetes mellitus to (T2D). IR is compounded by the development of other obesimetabolic dysfunction that associates with obesity This includes type 2 diabetes mellitus ty-related conditionsovary suchsyndrome as obstructive (OSA) [7] [6]. WithInexcess adiposity and obesity in the development of and the effects of IR on the this concise review (summarised in Figure 1), we explore the role of weight gain subsequent development of both metabolic and cognitive dysfunction.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have